Volunteer Assignments and Opportunities: Difference between revisions
| [checked revision] | [checked revision] |
No edit summary |
No edit summary |
||
| Line 1,270: | Line 1,270: | ||
| | | | ||
|- | |- | ||
| Leukemic Non-Nodal Mantle Cell Lymphoma||Disease|| | | Leukemic Non-Nodal Mantle Cell Lymphoma||Disease||Mahsa Khanlari, MD | ||
| | | | ||
| | | | ||
|?PENDING | |||
| | | | ||
|SP | |SP | ||
| Line 1,316: | Line 1,316: | ||
|26/10/2021 | |26/10/2021 | ||
|26/1/2022 | |26/1/2022 | ||
| | |PENDING | ||
| ||GC | | ||GC | ||
| | | | ||
| Line 1,388: | Line 1,388: | ||
|6/1/21 | |6/1/21 | ||
| | | | ||
| | |PENDING | ||
| ||GC | | ||GC | ||
| | | | ||
| Line 1,420: | Line 1,420: | ||
|10/26/2021 | |10/26/2021 | ||
|1/26/2022 | |1/26/2022 | ||
| | |PENDING | ||
| ||GC | | ||GC | ||
| | | | ||
| Line 1,428: | Line 1,428: | ||
|10/26/2021 | |10/26/2021 | ||
|1/26/2022 | |1/26/2022 | ||
| | |PENDING | ||
| ||GC | | ||GC | ||
| | | | ||
| Line 1,436: | Line 1,436: | ||
|10/26/2021 | |10/26/2021 | ||
|1/26/2022 | |1/26/2022 | ||
| | |PENDING | ||
| ||GC | | ||GC | ||
| | | | ||
| Line 1,452: | Line 1,452: | ||
|10/13/21 | |10/13/21 | ||
| | | | ||
| | |PENDING | ||
| ||GC | | ||GC | ||
| | | | ||
| Line 1,468: | Line 1,468: | ||
|30/05/21 | |30/05/21 | ||
|30/08/21 | |30/08/21 | ||
| | |PENDING | ||
| ||GC | | ||GC | ||
| | | | ||
| Line 1,476: | Line 1,476: | ||
|7/30/21 | |7/30/21 | ||
|10/30/21 | |10/30/21 | ||
| | |PENDING | ||
| ||GC | | ||GC | ||
| | | | ||